• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Expert Rev Mol Diagn . The Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in COVID-19: A Systematic Review and Meta-Analysis

tetano

Editor, Senior Moderator
Expert Rev Mol Diagn


. 2021 Apr 10.
doi: 10.1080/14737159.2021.1915773. Online ahead of print.
The Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in COVID-19: A Systematic Review and Meta-Analysis


Ahmed Abdelaal Ahmed Mahmoud M Alkhatip[SUP] 1 2 [/SUP], Mohamed Gomaa Kamel[SUP] 3 [/SUP], Mohamed Khaled Hamza[SUP] 4 [/SUP], Ehab Mohamed Farag[SUP] 2 [/SUP], Hany Mahmoud Yassin[SUP] 5 [/SUP], Mohamed Elayashy[SUP] 4 [/SUP], Amr Ahmed Naguib[SUP] 4 [/SUP], Mohamed Wagih[SUP] 4 [/SUP], Fatma Abd-Elshahed Abd-Elhay[SUP] 3 [/SUP], Haytham Zien Algameel[SUP] 6 [/SUP], Mohammed A Yousef[SUP] 7 [/SUP], Andrew Purcell[SUP] 8 [/SUP], Mohamed Helmy[SUP] 4 [/SUP]



Affiliations

Abstract

Background: The world urgently requires surrogate markers to diagnose COVID-19 and predict its progression. The severity is not easily predicted via currently used biomarkers. Critical COVID-19 patients need to be screened for hyperinflammation to improve mortality but expensive cytokine measurement is not routinely conducted in most laboratories. The neutrophil-to-lymphocyte ratio (NLR) is a novel biomarker in patients with various diseases. We evaluated the diagnostic and prognostic accuracy of the NLR in COVID-19 patients.
Methods: We searched for relevant articles in seven databases. The quantitative analysis was conducted if at least two studies were evaluating the NLR role in COVID-19.
Results: We included 8,120 individuals, including 7,482 COVID-19 patients, from 32 articles. Patients with COVID-19 had significantly higher levels of NLR compared to negative individuals. Advanced COVID-19 stages had significantly higher levels of NLR than earlier stages.
Conclusions: We found significantly higher levels of NLR in advanced stages compared to earlier stages of COVID-19 with good accuracy to diagnose and predict the disease outcome, especially mortality prediction. A close evaluation of critical SARS-CoV-2 patients and efficient early management are essential measures to decrease mortality. NLR could help in assessing the resource allocation in severe COVID-19 patients even in restricted settings.

Keywords: Neutrophil-to-Lymphocyte Ratio ? COVID-19 ? Coronavirus ? Diagnosis ? Prognosis ? Systematic Review ? Meta-analysis.
 
Back
Top Bottom